Trigger
Contact us

Unique discovery platform: Using metabolic data to discover safer, more impactful therapies

Until recently, the role of systemic and tumor metabolism in cancer care has been ignored. Faeth’s MetabOS platform provides unprecedented insights into drug-nutrient interactions across all tumor types. By incorporating metabolic optimization through diet, Faeth is unlocking an entirely new way of treating cancer. We pair our anti-cancer drugs with precision diets or other metabolism focused drugs to achieve greater outcomes and decrease toxicity.
MetabOS 1.5.24 v2

A new pillar of cancer care

Faeth’s therapeutic programs combine anti-cancer drugs with precision diets that are specifically designed to increase the efficacy and decrease the adverse events of the drug, making Faeth’s treatments more impactful against tumors and easier to tolerate for patients.
cancer_care
Group 14@2x

Backed by leading investors

s2gVentures
futureventures
digitalis
kdtventures
agfunder
cantos
unshackledventures